Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus
- PMID: 20332124
- PMCID: PMC2921795
- DOI: 10.1530/EJE-10-0049
Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus
Abstract
Objective: We examined the relationship of inflammatory and endothelial dysfunction markers with the prevalence and incidence of gross proteinuria (GP) in persons with type 1 diabetes mellitus.
Design: A longitudinal population-based cohort of persons with type 1 diabetes mellitus was followed from 1990-1992 through 2005-2007.
Methods: Prevalence and 15-year cumulative incidence of GP were defined as outcome variables. Serum high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), soluble vascular cell adhesion molecule-1 (VCAM-1), soluble intercellular adhesion molecule-1, and serum total homocysteine were measured. Multivariate logistic and discrete linear logistic regression modeling was used for data analysis.
Results: After controlling for duration of diabetes and other confounding factors, TNF-alpha (odds ratio (OR) 3.64; 95% confidence interval (CI) 2.33, 5.70), IL-6 (OR 1.41; 95% CI 1.06, 1.88), VCAM-1 (OR 13.35; 95% CI 5.39, 33.07), and homocysteine (OR 2.98; 95% CI 1.73, 5.16) were associated with prevalent proteinuria. Only hsCRP (OR 1.47; 95% CI 1.02, 2.11) was associated with incident proteinuria.
Conclusions: These findings suggest a role of inflammation and endothelial dysfunction as markers and contributors of the development of diabetic nephropathy in persons with type 1 diabetes mellitus.
Similar articles
-
Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus.Am Heart J. 2010 Jun;159(6):1074-80. doi: 10.1016/j.ahj.2010.03.023. Am Heart J. 2010. PMID: 20569722 Free PMC article.
-
The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.Arch Ophthalmol. 2009 Sep;127(9):1175-82. doi: 10.1001/archophthalmol.2009.172. Arch Ophthalmol. 2009. PMID: 19752427 Free PMC article.
-
Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.JAMA Ophthalmol. 2014 Apr 1;132(4):446-55. doi: 10.1001/jamaophthalmol.2013.7671. JAMA Ophthalmol. 2014. PMID: 24481424 Free PMC article.
-
Effect of flaxseed supplementation on markers of inflammation and endothelial function: A systematic review and meta-analysis.Cytokine. 2020 Feb;126:154922. doi: 10.1016/j.cyto.2019.154922. Epub 2019 Nov 15. Cytokine. 2020. PMID: 31739218
-
Systemic inflammatory markers and risk of dementia.Am J Alzheimers Dis Other Demen. 2006 Aug-Sep;21(4):258-62. doi: 10.1177/1533317506289260. Am J Alzheimers Dis Other Demen. 2006. PMID: 16948290 Free PMC article. Review.
Cited by
-
Genetic and Biological Effects of ICAM-1 E469K Polymorphism in Diabetic Kidney Disease.J Diabetes Res. 2020 Jun 12;2020:8305460. doi: 10.1155/2020/8305460. eCollection 2020. J Diabetes Res. 2020. PMID: 32626783 Free PMC article. Review.
-
Effect of propylene glycol mannate sulfate on non-proliferative diabetic retinopathy.Am J Transl Res. 2024 Jun 15;16(6):2509-2516. doi: 10.62347/URTF9525. eCollection 2024. Am J Transl Res. 2024. PMID: 39006273 Free PMC article.
-
The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis.Inflamm Res. 2019 Apr;68(4):275-284. doi: 10.1007/s00011-019-01220-4. Epub 2019 Feb 23. Inflamm Res. 2019. PMID: 30798334
-
Biochemical and clinical markers of endothelial dysfunction do not outweigh traditional risk factors for the presence of diabetic retinopathy in patients with type 1 diabetes.Diabetol Metab Syndr. 2022 Sep 27;14(1):141. doi: 10.1186/s13098-022-00912-y. Diabetol Metab Syndr. 2022. PMID: 36167607 Free PMC article.
-
Levels of Inflammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy.J Diabetes Res. 2018 Apr 4;2018:8546423. doi: 10.1155/2018/8546423. eCollection 2018. J Diabetes Res. 2018. PMID: 29850610 Free PMC article.
References
-
- Parving HH, Hovind P, Rossing K, Andersen S. Evolving strategies for renoprotection: diabetic nephropathy. Current Opinion in Nephrology and Hypertension. 2001;10:515–522. - PubMed
-
- Krempf M. Specifics of diabetic nephropathy, viewpoint in diabetology: trends of diabetic nephropathy in diabetes. Nephrologie & Therapeutique. 2006;2(Suppl 3):S190–S192. - PubMed
-
- Stitt AW, Jenkins AJ, Cooper ME. Advanced glycation end products and diabetic complications. Expert Opinion in Investigational Drugs. 2002;11:1205–1223. - PubMed
-
- Rossing P. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus. Diabetic Medicine. 1998;15:900–919. - PubMed
-
- Navarro JF, Mora C, Maca M, Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases. 2003;42:53–61. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous